Navigation Links
Nuvelo Reports Second Quarter 2008 Financial Results
Date:7/23/2008

target="_new">http://www.nuvelo.com.

The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at http://www.earnings.com, Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents (http://www.streetevents.com), a password-protected event management site.

About Nuvelo

Nuvelo, Inc. is dedicated to improving the lives of patients through the discovery, development and commercialization of novel drugs for acute cardiovascular disease, cancer and other debilitating medical conditions. Nuvelo's development pipeline includes NU172, a direct thrombin inhibitor in Phase 1 development for use as a potential short-acting anticoagulant during medical or surgical procedures; and preclinical candidate NU206, a Wnt pathway modulator for the potential treatment of chemotherapy/radiation therapy- induced mucositis and inflammatory bowel disease. In addition, Nuvelo is pursuing research programs in leukemia and lymphoma therapeutic antibodies and Wnt signaling pathway therapeutics to further expand its pipeline and create additional partnering and licensing opportunities.

Information about Nuvelo is available at our website at http://www.nuvelo.com or by phoning 650-517-8000.

This press release contains "forward-looking statements," which include statements regarding the timing, progress and anticipated completion of Nuvelo's clinical stage and research programs, the potential benefits that patients may experience from the use of our clinical stage compounds, and our anticipated use of cash, which statements are hereby identified as "forward- looking statements" for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of
'/>"/>

SOURCE Nuvelo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Nuvelo Reports First Quarter 2008 Financial Results and Updated Outlook for 2008
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. QMed, Inc. Reports July Medicare SNP Enrollments
4. Phlo Affiliate Reports Expanded Coverage to Oregon Border
5. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
6. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
7. Carrington Reports Second Quarter 2007 Results
8. Avitar Reports Third Quarter Financial Results for Fiscal 2007
9. Response Genetics Reports Second Quarter 2007 Financial Results
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Transgenomic, Inc. Reports Second Quarter 2007 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...e-FirstCall/--deCODE,genetics,Inc.(Nasdaq: DCGN )t...StockMarketthattradinginthecompany,scommonstockwil...befiledwiththe,SecuritiesandExchangeCommission,whi...q,unlessthecompanyfilesanappealtotheNasdaq,Listing...,which,willstaythesuspensionanddelistingthroughthe...
(Date:11/24/2009)...tCall/--NeurogesX,Inc.(Nasdaq: NGSX ),abiopharmace...novelpainmanagementtherapies,announcedtodaythatAnt...heduledtopresentatthe21stAnnualPiperJaffrayHealthC...PalaceHotelinNewYork,NewYork. ,, Mr.DiTonnoandS...bletorespondtoquestionsduringthepresentationsandto...
(Date:11/24/2009)...RNewswire-FirstCall/-HamiltonThorneLtd.(TSX-V:HTL)...ncedlasersystemsandinstrumentsforthestemcellresear...alandfinancialresultsforthethirdquarterendedSeptem...millioncomparedwith$1.43millioninQ32008,-Grossprof...2008,-Netlossreducedto$148,000comparedto$283,000in...
(Date:11/24/2009)...tomers with Partners Validated to Process and Anal... Ottawa, ON (PRWEB) Novemb...f products for biological sample collection, stabi...global partner program. The program offers signifi...ity and is designed to help partners scale and dif...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...S, Oct. 15 Strategic Healthcare,Group LLC announc...with the,American Red Cross to provide Strategic B...100 American Red Cross client hospitals across the...ighly successful Strategic Blood,Management(TM) pr...,Birmingham Hospital and Baptist Hospital in Pensa...
...a., Oct. 15 Cryo-Cell,International, Inc. (OTC Bu...rld,s largest and most established family cord blo...arter and nine months ended August 31,2008., Cons...ximately $4.5,million compared to approximately $4...any reported a net loss in the third quarter 2008 ...
...ent Medical Education Agency Expanding Industry Co...hcare,Communications LLC, an independent, full-ser... hiring of Todd Weinstein as Vice President, Busin...erience in medical education and,publishing as the...M, he,served as Manager of Publication Sales at Mc...
Other Biology Technology:American Red Cross Expands Agreement for Strategic Blood Management(TM) Services from Strategic Healthcare Group LLC 2Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 2Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 3Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 4Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 5Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 6L&M Healthcare Communications LLC Expands Client Services With Executive Team Expansion 2
(Date:11/25/2009)...at may be just as vital to your health as what you...Biological Studies. Their experiments in mice reve... of genes in the liverthe body,s metabolic clearin...by the body,s circadian clock as conventional wisd...tivity of a large number of genes completely indep...
(Date:11/24/2009)...tute (LRI) today named 12 new grant recipients for...e innovative work across a broad spectrum of lupus... novelty, and potential to drive scientific discov...plex disease of systemic lupus. , The 2009 grant... across the nation and include interdisciplinary a...
(Date:11/24/2009)...ised a protein that may help gut bacteria bind to ...sed by probiotic producers to identify strains tha...Probiotics need to interact with cells lining the ...h to surfaces in the gut they are more likely to s...says Dr Nathalie Juge from the Institute of Food R...
Breaking Biology News(10 mins):Feeding the clock 2Feeding the clock 3Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3A sticky solution for identifying effective probiotics 2Hisamitsu Pharmaceutical Co Inc Begins Tender Offer for All Outstanding Shares of Noven Pharmaceuticals Inc 52504 1Hisamitsu Pharmaceutical Co Inc Begins Tender Offer for All Outstanding Shares of Noven Pharmaceuticals Inc 52504 2Webcast Alert 3A Isis Pharmaceuticals Second Quarter 2009 Financial Results Conference Call 52501 1Webcast Alert 3A Isis Pharmaceuticals Second Quarter 2009 Financial Results Conference Call 52501 2Employee Wellness Programs Demonstrate Positive Return on Investment for Businesses 52498 1Employee Wellness Programs Demonstrate Positive Return on Investment for Businesses 52498 2Employee Wellness Programs Demonstrate Positive Return on Investment for Businesses 52498 3
... Screening for mutations in a gene that helps the...n drug may predict which children are at higher ri...lood cell count or organ rejection, according to n...ature journal Clinical Pharmacology and Therapeu...uld also help physicians tailor personalized anti-...
...s often thought of as harmful yet few know that ba... research the role of bacteria in water treatment,...ing with three leading institutions across three c...f cell-to-cell communication in bacteria. A greate... come up with better solutions for water and waste...
...ated Ocean Drilling Program (IODP) will conduct sc...e of its platforms in 2009, from March until Decem...tions in 2004 that all three platforms will operat...ed aboard the Chikyu; the newly modernized JOIDES ...ion-specific operations will be conducted using pl...
Other Biology News:Gene mutation increases drug toxicity, rejection risk in pediatric kidney transplants 2Gene mutation increases drug toxicity, rejection risk in pediatric kidney transplants 3NTU seals global partnerships on environmental sciences R&D 2IODP to operate 3 drilling platforms in 2009 2
iEMS Incubator/Shaker 2 module from Thermo Scientific
...is a modified cap analog in which the 3 OH group (...his substitution, the RNA polymerase can only init...up thus forcing ARCA incorporation in the forward ...esized with conventional cap analog, 100% of the t...
RNA Cap Analog, Unmethylated from EPICENTRE Biotechnologies
Stackable Refrigerated Shaker, 230V, 50 Hz from Thermo Scientific
Biology Products: